Viewing Study NCT03406156

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-05-18 @ 1:47 PM
Study NCT ID: NCT03406156
Status: COMPLETED
Last Update Posted: 2024-08-06
First Post: 2018-01-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia (CLL) View
None Small Lymphocytic Lymphoma (SLL) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Chronic Lymphocytic Leukemia View
None 17p Deletion View
None Debulking View
None Obinutuzumab View
None Bendamustine View
None Tumor lysis syndrome View
None Venetoclax View
None Small Lymphocytic Lymphoma View